Navigation Links
Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007

MINNEAPOLIS, May 23, 2007 (BUSINESS WIRE) -- MGI PHARMA, INC. (NASDAQ:MOGN), a biopharmaceutical company focused in oncology and acute care, today announced the presentation of results of a successful pivotal phase 3 trial of Aquavan(R) (fospropofol disodium) Injection in patients undergoing colonoscopy. Primary and secondary efficacy endpoint results, as well as safety data, were presented at Digestive Disease Week 2007 in Washington, D.C. by Lawrence B. Cohen, MD, Department of Medicine/ Gastroenterology, Mount Sinai School of Medicine, New York.

Aquavan Injection is a proprietary water-soluble prodrug of propofol that is in clinical development for moderate sedation of patients undergoing therapeutic and diagnostic procedures. Aquavan has not yet been approved for marketing by the U.S. Food and Drug Administration (U.S. FDA) or any other regulatory agencies.

"Aquavan has a favorable pharmacokinetic profile, making it possible to deliver a predictable concentration of sedative and achieve the desired level of sedation," said Dr. Cohen, a lead investigator of the trial.

Colonoscopy Results: Primary Endpoint of Sedation Success Achieved (Abstract W1451)

A randomized, double-blind, multi-center phase 3 pivotal trial was conducted to evaluate whether an Aquavan dosing regimen of 6.5 mg/kg would be safe and effective in providing moderate sedation in patients undergoing colonoscopy, compared to a 2.0 mg/kg Aquavan regimen. A total of 312 patients in 18 sites were pre-treated with fentanyl citrate (50 (mu)g) and then received either Aquavan 2.0 mg/kg, Aquavan 6.5 mg/kg or midazolam 0.02 mg/kg (2:3:1 ratio). Gastroenterologists administered the sedatives, as is consistent with a large percentage of routine colonoscopies. Patients were ages 18 and older and in varying states of health and sedation risk.

The results showed that 87% of patients who received an initial bolus dose
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study of Aquavan Injection in Patients Undergoing Bronchoscopy
2. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
3. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
4. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
5. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
6. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
7. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
8. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
9. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
10. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
11. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
Post Your Comments:
(Date:8/29/2014)... Aug. 29, 2014 The Competitive Intelligence (CI) ... marketplace changes. CI leaders who adjust will succeed, and ... a new Best Practices, LLC study CI leaders from ... including: - Use secondary research whenever possible ... - Internal staff who are creative thinkers ...
(Date:8/29/2014)... Aug. 29, 2014 Medina Medical announced today ... member of the Board of Directors on August 18, ... development and commercialization experience, including over a decade of ... served as a Partner of the medical device incubator ... of two Foundry start-ups. Mr. Engelson previously served as ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and Markets ... Drug Pipeline Insight 2014" report to their offering. ... US is one of the largest segments of pharmaceuticals industry. ... rate, while the available therapies were unable to meet the ... the market for CNS disorder, especially over the past two ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2US CNS Disorders Drug Pipeline Insight 2014 2
... 2012 Allscripts (NASDAQ: MDRX) today announced that ... ™ to manage the revenue cycle for 39 affiliated providers ... integrated Allscripts Electronic Health Record (EHR) to automate ... the insights they need to deliver superior patient care. ...
... SAN FRANCISCO, Jan. 4, 2012  Practice Fusion, the ... community in the US, announced today that its ... a faster, simpler and more streamlined user experience ... technology flagged more than 7,000 deadly drug interactions ...
Cached Medicine Technology:Mammoth Hospital Selects Allscripts RCM Services 2Mammoth Hospital Selects Allscripts RCM Services 3Mammoth Hospital Selects Allscripts RCM Services 4Mammoth Hospital Selects Allscripts RCM Services 5Practice Fusion's Top-Rated e-Prescribing Software Gets a Doctor-Driven Makeover 2Practice Fusion's Top-Rated e-Prescribing Software Gets a Doctor-Driven Makeover 3
(Date:8/29/2014)... The new review that can be read on DailyGossip.org indicates ... will permanently eliminate the symptoms of this disease. , ... cure in as fast as 30 to 60 days. However, ... week. , The Tinnitus Miracle review indicates that this ... loss, pain in the ear and dizziness. Read the full ...
(Date:8/29/2014)... Cosmetic Town is a cosmetic ... plastic surgeons with prospective patients. The site showcases ... techniques in plastic and reconstructive surgery. Articles are ... reliable information for general readers, who are looking ... Town began featuring renowned cosmetic specialists from Los ...
(Date:8/29/2014)... The Nasal Polyps Treatment Miracle ... new program is actually based on some powerful ... by a former nasal polyps sufferer, who in ... problem. Manuel Richards suffered from nasal polyps for ... , Learn more about Manuel Richards' new book ...
(Date:8/29/2014)... The Department of Health and Human ... code CMS–0052–P) today allowing healthcare providers to attest for ... EHR Technology (CEHRT) or a combination of the 2011 ... not been able to fully implement 2014 Edition CEHRT ... continue to use 2011 Edition CEHRT, or a combination ...
(Date:8/29/2014)... Indosoft, Inc., a leading provider of scalable Asterisk-based ... licensing of its Q-Suite 5.7 software. As a ... been successfully deploying and supporting its ACD and Dialer ... the world for more than a decade. The introduction ... option which complements the widespread deployment of Q-Suite in ...
Breaking Medicine News(10 mins):Health News:Tinnitus Miracle Review Reveals How to Gain Tinnitus Relief in 7 Days 2Health News:Cosmetic Town Is Now Connecting Patients with Qualified Cosmetic Specialists 2Health News:Nasal Polyps Treatment Miracle Review Exposes New Natural and Permanent Healing Program 2Health News:Quirk Healthcare Outlook on MU2 Delay Confirmation 2Health News:Indosoft Offers Monthly Usage Licensing Terms 2
... of a ban on Coke and Pepsi by the Kerala Government, ... putting forth a proposal to stop the sale// and production of ... ,Top brass in the companies are very unhappy over these ... private company which is not in sync with the reports ...
... Minister Tony Abbott yesterday accused the commonwealth of bankrolling ... public money was spent.// ,He attacked ... should be able to fund public hospitals using the ... ,State health ministers, outraged at Mr Abbott's position accused ...
... too much take-away food and pile on weight will soon ... ,The National Heart Foundation's tick is a label that ... and will soon make its appearance at restaurants, take-away outlets ... by analyst BIS Shrapnel who showed that 70 percent of ...
... for one to undergo an operation.// ,A team ... analysed the outcomes of over 90,000 operations carried out at ... time to have an operation, as they had found that ... published their study in the journal Quality and Safety in ...
... eating raw shellfish have made the U.S. Food and ... raw shellfish. Reports coming// in show that oysters and ... sick across the country. ,Till date there have been ... gastroenteritis after eating raw shellfish. The illness is caused ...
... condition that affects children as well as adults. A ... alleviate// symptoms and bring down the inflammation associated with ... 10 issue of the New England Journal of Medicine. ... the National Institute of Arthritis and Musculoskeletal and Skin ...
Cached Medicine News:Health News:Health Minister Slams State Health Governments 2Health News:Heart Tick for Fast Foods in Australia 2Health News:Surgeries Performed In The Morning Have Less Post-Op Complications 2Health News:NOMID Symptoms Helped By Arthritis Drug 2Health News:NOMID Symptoms Helped By Arthritis Drug 3
... Skin Staple Remover is a plastic ... is packaged 12 units per box ... staples. The device works by slipping ... under the staple to be removed. ...
... place single staples to close surgical ... stainless steel; the staplers are not ... skin staplers to meet your needs., ... for routine skin closure in a ...
... is a full-feature skin stapler with a ... has improved visibility over existing fixed-head skin ... for easier staple placement., ,This Skin ... instrument designed to deliver rectangular, stainless steel ...
... Linear Staplers are available with either a ... instrument (non-reloadable). Each instrument contains 19 staples ... ,Benefits include: , Small profile stapling head ... , Articulating head rotates up to 80deg; ...
Medicine Products: